Zomedica Corp. ZOM · Stock Open Zomedica Corp. in new tab
Zomedica Corp. Analysis (ZOM)
Is Zomedica Corp. a good investment? Zomedica Corp. (ZOM) is currently trading at 0.0973 USD.
Earnings Schedule: Zomedica Corp. is expected to release its next earnings report on Nov. 5, 2025.
Investor FAQ
Does Zomedica Corp. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Zomedica Corp.?
Zomedica Corp. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2025. The company currently has a trailing EPS of -0.06.
Company Profile
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.
Community Discussion